SJS Investment Consulting’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.4K Sell
37
-53
-59% -$22.4K ﹤0.01% 922
2026
Q1
$42.6K Buy
90
+38
+73% +$19.1K 0.01% 447
2025
Q4
$24.3K Buy
52
+15
+41% +$6.96K ﹤0.01% 573
2025
Q3
$15.8K Buy
37
+23
+164% +$8.91K ﹤0.01% 564
2025
Q2
$5.37K Sell
14
-2
-13% -$721 ﹤0.01% 399
2025
Q1
$5.53K Hold
16
﹤0.01% 442
2024
Q4
$4.8K Sell
16
-3
-16% -$1.05K ﹤0.01% 445
2024
Q3
$7.72K Hold
19
﹤0.01% 408
2024
Q2
$6.11K Hold
19
﹤0.01% 407
2024
Q1
$6.34K Buy
19
+1
+6% +$306 ﹤0.01% 421
2023
Q4
$4.87K Sell
18
-2
-10% -$494 ﹤0.01% 393
2023
Q3
$4.92K Sell
20
-1
-5% -$274 ﹤0.01% 378
2023
Q2
$6.37K Hold
21
﹤0.01% 319
2023
Q1
$5.54K Hold
21
﹤0.01% 358
2022
Q4
$5.04K Buy
21
+6
+40% +$1.34K ﹤0.01% 358
2022
Q3
$3K Buy
+15
New +$2.99K ﹤0.01% 384
2022
Q1
$1K Buy
+2
New +$502 ﹤0.01% 580

Other funds holding HCA

SJS Investment Consulting's HCA Position: Q2 2026 in Review

SJS Investment Consulting reduced its HCA Healthcare (HCA) stake by 59% in Q2 2026, selling an estimated $22.4K and leaving 37 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

SJS Investment Consulting first reported a position in HCA in Q1 2022 and has held it in 17 quarters since. The position peaked at $42.6K in Q1 2026. 782 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • SJS Investment Consulting held 37 shares of HCA Healthcare worth $14.4K as of Q2 2026.
  • SJS Investment Consulting sold 53 HCA Healthcare shares in Q2 2026, an estimated $22.4K.
  • HCA Healthcare made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #922 holding.
  • SJS Investment Consulting first reported a position in HCA Healthcare in Q1 2022 and has held it in 17 quarters since.
  • SJS Investment Consulting's HCA Healthcare position peaked at $42.6K in Q1 2026.
  • 782 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.